Literature DB >> 15372566

Isolation, crystal and solution structure determination, and biosynthesis of tubulysins--powerful inhibitors of tubulin polymerization from myxobacteria.

Heinrich Steinmetz1, Nicole Glaser, Eberhardt Herdtweck, Florenz Sasse, Hans Reichenbach, Gerhard Höfle.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15372566     DOI： 10.1002/anie.200460147

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  24 in total

1.  2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities.

Authors:  Mukund P Tantak; Jing Wang; Rajnish Prakash Singh; Anil Kumar; Kavita Shah; Dalip Kumar
Journal:  Bioorg Med Chem Lett       Date:  2015-08-06       Impact factor: 2.823

2.  Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.

Authors:  William C Floyd; Gopal K Datta; Shinichi Imamura; Heidi M Kieler-Ferguson; Katherine Jerger; Andrew W Patterson; Megan E Fox; Francis C Szoka; Jean M J Fréchet; Jonathan A Ellman
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

Review 3.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

Review 4.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

5.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

6.  Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates.

Authors:  Leanna R Staben; Stefan G Koenig; Sophie M Lehar; Richard Vandlen; Donglu Zhang; Josefa Chuh; Shang-Fan Yu; Carl Ng; Jun Guo; Yanzhou Liu; Aimee Fourie-O'Donohue; MaryAnn Go; Xin Linghu; Nathaniel L Segraves; Tao Wang; Jinhua Chen; BinQing Wei; Gail D Lewis Phillips; Keyang Xu; Katherine R Kozak; Sanjeev Mariathasan; John A Flygare; Thomas H Pillow
Journal:  Nat Chem       Date:  2016-10-17       Impact factor: 24.427

7.  Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads.

Authors:  Carolyn A Leverett; Sai Chetan K Sukuru; Beth C Vetelino; Sylvia Musto; Kevin Parris; Jayvardhan Pandit; Frank Loganzo; Alison H Varghese; Guoyun Bai; Bin Liu; Dingguo Liu; Sarah Hudson; Venkata Ramana Doppalapudi; Joseph Stock; Christopher J O'Donnell; Chakrapani Subramanyam
Journal:  ACS Med Chem Lett       Date:  2016-08-26       Impact factor: 4.345

8.  In vitro efficacy of Myxococcus fulvus ANSM068 to biotransform aflatoxin B₁.

Authors:  Shu Guan; Lihong Zhao; Qiugang Ma; Ting Zhou; Ning Wang; Xinxu Hu; Cheng Ji
Journal:  Int J Mol Sci       Date:  2010-10-20       Impact factor: 5.923

9.  Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.

Authors:  Gurmeet Kaur; Melinda Hollingshead; Susan Holbeck; Vesna Schauer-Vukasinović; Richard F Camalier; Alexander Dömling; Seema Agarwal
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

10.  Total synthesis and biological evaluation of tubulysin U, tubulysin V, and their analogues.

Authors:  Ranganathan Balasubramanian; Bhooma Raghavan; Adrian Begaye; Dan L Sackett; Robert A Fecik
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.